CF PharmTech completes placement of 21,747,700 new H shares at HK$ 13.82 each

• CF PharmTech completed a private placement of 21,747,700 new H shares on Aug. 6, 2026 at HK$ 13.82 each.
• Gross proceeds HK$ 300.55 million; net proceeds HK$ 294.81 million; net issue price HK$ 13.56 per share.
• New shares equal 6.74% of H shares outstanding, 5.03% of total shares outstanding, excluding treasury shares.
• Shares placed with at least six investors; none became a substantial shareholder.
• Proceeds earmarked 70% for innovative drug development; 15% for complex inhalation products; 15% for working capital.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CF Pharmtech Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260806-12276137), on August 06, 2026, and is solely responsible for the information contained therein.